Description

Book Synopsis
This compilation comprises 6 chapters, each detailing a recent advancement in medicine and biology. Chapter 1 deals with tuberculosis (TB), describing current knowledge of disease pathogenesis, epidemiology of TB and drug-resistant TB, evolution and molecular mechanisms of drug resistance, fitness compensatory mechanisms and laboratory methods for the diagnosis of susceptible and drug-resistant TB. Chapter 2 details the use of B cell-targeted therapy for treatment of autoimmune and chronic inflammatory diseases. Chapter 3 concerns peptic ulcer disease and the various therapeutic approaches used to treat ulcers or lesions in the gastrointestinal tract. Chapter 4 discusses the efficacity of in vitro cultures of Astragalus for biomass and secondary metabolite production. Chapter 5 describes the B lymphocyte activation factor (BAFF), a potent cell-survival factor expressed in many hematopoietic cells. Finally, Chapter 6 presents a review of the literature to determine the relationship between non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and hepatocellular carcinoma to establish a guideline for monitoring patients.

Advances in Medicine and Biology: Volume 177

    Product form

    £177.59

    Includes FREE delivery

    RRP £221.99 – you save £44.40 (20%)

    Order before 4pm today for delivery by Thu 25 Jun 2026.

    A Hardback by Leon V. Berhardt

    1 in stock

      Trusted by thousands of customers. See 2,385+ Customer Reviews

      View other formats and editions of Advances in Medicine and Biology: Volume 177 by Leon V. Berhardt

      Publisher: Nova Science Publishers Inc
      Publication Date: 15/04/2021
      ISBN13: 9781536194913, 978-1536194913
      ISBN10: 1536194913

      Description

      Book Synopsis
      This compilation comprises 6 chapters, each detailing a recent advancement in medicine and biology. Chapter 1 deals with tuberculosis (TB), describing current knowledge of disease pathogenesis, epidemiology of TB and drug-resistant TB, evolution and molecular mechanisms of drug resistance, fitness compensatory mechanisms and laboratory methods for the diagnosis of susceptible and drug-resistant TB. Chapter 2 details the use of B cell-targeted therapy for treatment of autoimmune and chronic inflammatory diseases. Chapter 3 concerns peptic ulcer disease and the various therapeutic approaches used to treat ulcers or lesions in the gastrointestinal tract. Chapter 4 discusses the efficacity of in vitro cultures of Astragalus for biomass and secondary metabolite production. Chapter 5 describes the B lymphocyte activation factor (BAFF), a potent cell-survival factor expressed in many hematopoietic cells. Finally, Chapter 6 presents a review of the literature to determine the relationship between non-alcoholic fatty liver disease, non-alcoholic steatohepatitis and hepatocellular carcinoma to establish a guideline for monitoring patients.

      Recently viewed products

      © 2026 Book Curl

        • American Express
        • Apple Pay
        • Diners Club
        • Discover
        • Google Pay
        • Maestro
        • Mastercard
        • PayPal
        • Shop Pay
        • Union Pay
        • Visa

        Login

        Forgot your password?

        Don't have an account yet?
        Create account